Control of cell proliferation in cancer prevention

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 428, Issue 1-2, 1999, Pages 291-298

  Mori, H ^a   Sugie, S ^a   Yoshimi, N ^a   Hara, A ^a   Tanaka, T ^b  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Carcinogenesis; Cell proliferation; Chemoprevention; Digestive organ

Indexed keywords

AFLATOXIN B1; ANTIOXIDANT; AROTINOID; ASTAXANTHIN; AZOXYMETHANE; BETA CAROTENE; CANTHAXANTHIN; CARCINOGEN; CHLOROGENIC ACID; COSTUNOLIDE; CURCUMIN; DIAMINE; DIETHYLNITROSAMINE; DIMETHYLBENZ[A]ANTHRACENE; DIOSMIN; DISULFIRAM; ELLAGIC ACID; FERULIC ACID; FLAVONOID; HESPERIDIN; METHYLAZOXYMETHANOL; MOFAROTENE; N (2 FLUORENYL)ACETAMIDE; PHENOL DERIVATIVE; PLUMBAGIN; PROTOCATECHUIC ACID; SINIGRIN; TELOMERASE; UNINDEXED DRUG;

APOPTOSIS; CANCER PREVENTION; CARCINOGENESIS; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLON CARCINOGENESIS; CONFERENCE PAPER; HUMAN; LIVER CARCINOGENESIS; LIVER CELL; MOUTH CANCER; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CELL DIVISION; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; DRUG SCREENING ASSAYS, ANTITUMOR; LIVER NEOPLASMS, EXPERIMENTAL; MOUTH NEOPLASMS; NEOPLASMS, EXPERIMENTAL; RATS;

RODENTIA;

EID: 0032788626     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(99)00055-1     Document Type: Conference Paper

References (48)

1. H. Mori, N. Yoshimi, T. Tanaka, Y. Hirose, Experimental colorectal carcinogenesis; role of cell proliferation, in: E. Tahara, K. Sugimachi, T. Oohara (Eds.), Recent Advances in Gastroenterological Carcinogenesis I, Monduzzi Editore, Bologna, 1996, pp. 249-254.
2. Wattenberg L.W. Chemoprevention of cancer. Cancer Res. 45:1985;1-8.
3. Mori H., Sugie S., Tanaka T., Makita H., Yoshimi Y. Suppressive effects of natural antioxidants on carcinogenesis in digestive organs. Environ. Mutagen Res. 18:1996;73-77.
4. Mori H., Tanaka T., Sugie S., Yoshimi N., Kawamori T., Hirose Y., Ohnishi M. Chemoprevention by naturally occurring and synthetic agents in oral, liver, and large bowel carcinogenesis. J. Cell. Biochem. 27:1997;35-41. Suppl.
5. Morse M.A., Stoner G.D. Cancer chemoprevention: principles and prospects. Carcinogenesis. 14:1993;1737-1746.
6. Yoshimi N., Ino N., Suzui M., Hara A., Nakatani K., Sato S., Mori H. Telomerase activity of normal tissues and neoplasms in rat colon carcinogenesis induced by methylazoxymethanol acetate and its difference from that of human colonic tissues. Mol. Carcinog. 16:1996;1-5.
7. Ohnishi M., Yoshimi N., Kawamori T., Ino N., Hirose Y., Tanaka T., Yamahara J., Miyata H., Mori H. Inhibitory effects of dietary protocatechuic acid and costunolide, on 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis. Jpn. J. Cancer Res. 88:1997;111-119.
8. Okumura A., Tanaka T., Mori H. Simultaneous measurement of unscheduled and replicating DNA synthesis by means of a new cell culture insert DNA retention method: rapid induction of replicating DNA synthesis in response to genotoxic carcinogens. Jpn. J. Cancer Res. 87:1996;805-815.
9. Hirose Y., Yoshimi N., Makita H., Hara A., Tanaka T., Mori H. Early alterations and cell proliferation in azoxymethane-initiated rat colonic epithelium. Jpn. J. Cancer Res. 87:1996;575-582.
10. H. Mori, T. Tanaka, S. Sugie, N. Yoshimi, T. Kawamori, Y. Hirose, T. Osawa, Protective role of dietary factors in carcinogenesis of digestive organs, in: H. Ohigashi, T. Osawa, J. Terao, S. Watanabe, T. Yoshikawa (Eds.), Food Factors for Cancer Prevention, Springer, Tokyo, 1997, pp. 98-102.
11. Tanaka T., Kojima T., Suzui M., Mori H. Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumor development and biomarkers expression of colon tumorigenesis. Cancer Res. 53:1993;3908-3913.
12. Mori H., Tanaka T., Shima H., Kuniyasu T., Takahashi M. Inhibitory effect of chlorogenic acid on methylazoxymethanol acetate-induced carcinogenesis in large intestine and liver of hamsters. Cancer Lett. 30:1986;49-54.
13. Tanaka T., Makita H., Kawamori T., Mori H., Kakumoto M., Satoh K., Hara A., Sumida T., Tanaka T., Ogawa H. Chemoprevention of azoxymerthane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis. 18:1997;957-965.
14. Tanaka T., Kawamori T., Ohnishi M., Makita H., Mori H., Satoh K., Hara A. Suppression of azoxymethane-induced rat colon carcinogenesis by dietary administration of naturally occurring xanthophylls astaxanthin and canthaxanthin during the postinitiation phase. Carcinogenesis. 16:1995;2957-2963.
15. S. Sugie, K. Okamoto, A. Okumura, T. Tanaka, H. Mori, Inhibitory effects of benzyl thiocyanate and benzyl isothiocyanate on methylazoxymethanol acetate-induced intestinal carcinogenesis, 15 (1994) 1555-1560.
16. Kawamori T., Tanaka T., Ohnishi M., Hirose Y., Nakamura Y., Satoh K., Hara A., Mori H. Chemoprevention of azoxymethane-induced colon carcinogenesis by dietary feeding of S-methylmethanethiosulfonate in male F344 rats. Cancer Res. 55:1995;4053-4058.
17. Tanaka T., Shinoda T., Yoshimi N., Niwa K., Iwata H., Mori H. Inhibitory effect of magnesium hydroxide on methylazoxymethanol acetate-induced large bowel carcinogenesis in male F344 rats. Carcinogenesis. 10:1989;613-616.
18. Mori H., Yoshimi N., Sugie S., Tanaka T., Morishita Y., Jinlong G., Tamai Y., Torihara M., Yamahara J. Inhibitory effect of 5-hydroxy-4-[2-phenyl-(E)-ethenyl]-2(5H)-furanone, a novel synthesized retinoid, on azoxymethane-induced intestinal carcinogenesis in rats. Cancer Lett. 66:1992;93-98.
19. Kawamori T., Tanaka T., Suzui M., Okamoto K., Tamai Y., Torihara M., Yamahara J., Mori H. Chemoprevention of azoxymethane-induced intestinal carcinogenesis by a novel synthesized retinoid, 5-hydroxy-4-[2-phenyl-(E)-ethenyl]-2(5H)-furanone, in rats. Carcinogenesis. 16:1995;795-800.
20. Mori H., Kawamori T., Tanaka T., Ohnishi M., Yamahara J. Chemopreventive effect of costunolide, a constituent of oriental medicine, on azoxymethane-induced intestinal carcinogenesis in rats. Cancer Lett. 83:1994;171-175.
21. Yoshimi N., Wang A., Morishita Y., Tanaka T., Sugie S., Kawai K., Yamahara J., Mori H. Modifying effects of fungal and herb metabolites on azoxymethane-induced intestinal carcinogenesis in rats. Jpn. J. Cancer Res. 83:1992;1273-1278.
22. Sugie S., Okamoto K., Rahman K.M.W., Tanaka T., Kawai K., Yamahara J., Mori H. Inhibitory effects of plumbagin and juglone on azoxymethane-induced intestinal carcinogenesis in rat. Cancer Lett. 127:1998;177-183.
23. Mori H., Morishita Y., Yoshimi N., Sugie S., Tanaka T. Effect of magnesium hydroxide on methylazoxymethanol acetate-induced epithelial proliferation in the large bowels of rats. Cancer Lett. 62:1992;43-48.
24. Wang A., Yoshimi N., Tanaka T., Mori H. Inhibitory effects of magnesium hydroxide on c-myc expression and cell proliferation induced by methylazoxymethanol acetate in rat colon. Cancer Lett. 75:1993;73-78.
25. Wang A., Yoshimi N., Tanaka T., Mori H. The inhibitory effect of magnesium hydroxide on the bile acid-induced cell proliferation of colon epithelium in rats with comparison to the action of calcium lactate. Carcinogenesis. 15:1994;2661-2663.
26. Tanaka T., Kawabata K., Kakumoto M., Makita H., Matsunaga K., Mori H., Satoh K., Hara A., Murakami A., Koshimizu K., Ohigashi H. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor 1′-acetoxychavicol acetate. Jpn. J. Cancer Res. 88:1997;821-830.
27. Tanaka T., Iwata H., Niwa K., Mori Y., Mori H. Inhibitory effect of ellagic acid on N-2-fluorenylacetamide-induced liver carcinogenesis in male ACI/N rats. Jpn. J. Cancer Res. (Gann). 79:1988;1297-1303.
28. Tanaka T., Mori Y., Morishita Y., Hara A., Ohno T., Kojima T., Mori H. Inhibitory effect of sinigrin and indole-3-carbinol on diethylnitrosamine-induced hepatocarcinogenesis in male ACI/N rats. Carcinogenesis. 11:1990;1403-1406.
29. Tanaka T., Kojima T., Kawamori T., Yoshimi N., Mori H. Chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis by a simple phenolic acid protocatechuic acid in rats. Cancer Res. 53:1993;2775-2779.
30. Okamoto K., Sugie S., Ohnishi M., Makita H., Kawamori T., Watanabe T., Tanaka T., Mori H. Chemopreventive effects of tauline on diethylnitrosamine and phenobarbital-induced hepatocarcinogenesis in male F344 rats. Jpn. J. Cancer Res. 87:1996;30-36.
31. Kojima T., Tanaka T., Kawamori T., Hara A., Mori H. Chemopreventive effects of dietary D,L-α-difluoromethylornithine, an ornithine decarboxylase inhibitor, on initiation and postinitiation stages of diethylnitrosamine-induced rat hepatocarcinogenesis. Cancer Res. 53:1993;3903-3907.
32. Sugie S., Okumura A., Tanaka T., Mori H. Inhibitory effects benzyl thiocyanate and benzyl isothiocyanate on diethylnitrosamine-induced hepatocarcinogenesis in rats. Jpn. J. Cancer Res. 84:1993;865-870.
33. Sugie S., Okamoto K., Ohnishi M., Makita H., Kawamori T., Watanabe T., Tanaka T., Nakamura Y.K., Nakamura Y., Tomita I., Mori H. Suppressive effects of S-methyl methanethiosulfonate on promotion stage of diethylnitrosamine-initiated and phenobarbital-promoted hepatocarcinogenesis model. Jpn. J. Cancer Res. 88:1997;5-11.
34. Sugie S., Okamoto K., Makita H., Ohnishi M., Kawamori T., Watanabe T., Tanaka T., Mori H. Inhibitory effect of chlorophyllin on diethylnitrosamine and phenobarbital-induced hepatocarcinogenesis in male F344 rats. Jpn. J. Cancer Res. 87:1996;1045-1051.
35. Sugie S., Okamoto K., Ueda F., Watanabe T., Tanaka T., Mori H. Suppressive effect of irsogladine maleate on diethylnitrosamine-initiated and phenobarbital-promoted hepatocarcinogenesis in male F344 rats. Jpn. J. Cancer Res. 89:1998;1-6.
36. Tanaka T., Kojima T., Mori Y., Mori H. Inhibitory effects of the natural products indole-3-carbinol and sinigrin during initiation and promotion phases of 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Jpn. J. Cancer Res. 83:1992;835-842.
37. Tanaka T., Kojima T., Kawamori T., Wang A., Suzui M., Okamoto K., Mori H. Inhibition of 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids. Carcinogenesis. 14:1993;1321-1325.
38. Tanaka T., Makita H., Ohnishi M., Hirose Y., Wang A., Mori H., Satoh K., Hara A., Ogawa H. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin; comparison with the protective effect of β-carotene. Cancer Res. 54:1994;4653-4659.
39. Tanaka T., Kawamori T., Ohnishi M., Okamoto K., Mori H., Hara A. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary protocatechuic acid during initiation and postinitiation phases. Cancer Res. 54:1994;2359-2365.
40. Tanaka T., Makita H., Ohnishi M., Mori H., Satoh K., Hara A., Sumida T., Fukutani K., Tanaka T., Ogawa H. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination. Cancer Res. 57:1997;246-252.
41. Makita H., Tanaka T., Fujitsuka H., Tatematsu N., Satoh K., Hara A., Mori H. Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone, and quercetin. Cancer Res. 56:1996;4904-4909.
42. Tanaka T., Makita H., Ohnishi M., Mori H., Satoh K., Hara A. Chemoprevention of oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxanthin. Cancer Res. 55:1995;4059-4064.
43. Ohnishi M., Tanaka T., Makita H., Kawamori T., Mori H., Satoh K., Hara A., Murakami A., Ohigashi H., Koshimizu K. Chemopreventive effect of a xanthine oxidase inhibitor, 1′-acetoxychavicol acetate, on rat oral carcinogenesis. Jpn. J. Cancer Res. 87:1996;349-356.
44. Makita H., Tanaka T., Ohnishi M., Tamai Y., Torihara M., Yamahara J., Mori H., Satoh K., Hara A. Inhibition of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by dietary exposure of a new retinoidal butenolide, KYN-54, during the initiation and post-initiation phases. Carcinogenesis. 16:1995;2171-2176.
45. Tanaka T., Makita H., Ohnishi M., Mori H., Satoh K., Hara A. Inhibition of oral carcinogenesis by the arotinoid mofarotene (RO 40-8757) in male F344 rats. Carcinogenesis. 16:1995;1903-1907.
46. Kawamori T., Tanaka T., Kojima T., Suzui M., Ohnishi M., Mori H. Suppression of azoxymethane-induced rat colon aberrant crypt foci by dietary protocatechuic acid. Jpn. J. Cancer Res. 85:1994;686-691.
47. Kawamori T., Tanaka T., Hirose Y., Ohnishi M., Mori H. Inhibitory effects of D-limonene on the development of colonic aberrant crypt foci by azoxymethane in F344 rats. Carcinogenesis. 17:1996;369-372.
48. Kawamori T., Tanaka T., Hara A., Yamahara J., Mori H. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats. Cancer Res. 55:1995;1277-1282.